|
1. Townsend, L. B.; Wise, D. S., The Synthesis and Chemistry of Certain Anthelmintic Benzimidazoles. Parasitol Today 1990, 6 (4), 107-112. 2. Chaudhari, V. K.; Pathak, D.; Singh, S., Benzimidazole: As potential biologically active agent. Int. Res. J. Pharm. 2014, 5 (12), 861-875. 3. Tuncbilek, M.; Kiper, T.; Altanlar, N., Synthesis and in vitro antimicrobial activity of some novel substituted benzimidazole derivatives having potent activity against MRSA. Eur J Med Chem 2009, 44 (3), 1024-1033. 4. Shingalapur, R. V.; Hosamani, K. M.; Keri, R. S., Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles. Eur J Med Chem 2009, 44 (10), 4244-4248. 5. Zhang, H. Z.; Damu, G. L. V.; Cai, G. X.; Zhou, C. H., Design, synthesis and antimicrobial evaluation of novel benzimidazole type of Fluconazole analogues and their synergistic effects with Chloromycin, Norfloxacin and Fluconazole. Eur J Med Chem 2013, 64, 329-344. 6. Hernandez-Luis, F.; Hernandez-Campos, A.; Castillo, R.; Navarrete-Vazquez, G.; Soria-Arteche, O.; Hernandez-Hernandez, M.; Yepez-Mulia, L., Synthesis and biological activity of 2-(trifluoromethyl)-1H-benzimidazole derivatives against some protozoa and Trichinella spiralis. Eur J Med Chem 2010, 45 (7), 3135-3141. 7. Valdez-Padilla, D.; Rodriguez-Morales, S.; Hernandez-Campos, A.; Hernandez-Luis, F.; Yepez-Mulia, L.; Tapia-Contreras, A.; Castillo, R., Synthesis and antiprotozoal activity of novel 1-methylbenzimidazole derivatives. Bioorgan Med Chem 2009, 17 (4), 1724-1730. 8. Rida, S. M.; El-Hawash, S. A. M.; Fahmy, H. T. Y.; Hazzaa, A. A.; El-Meligy, M. M. M., Synthesis of novel benzofuran and related benzimidazole derivatives for evaluation of in vitro anti-HIV-1, anticancer and antimicrobial activities. Arch Pharm Res 2006, 29 (10), 826-833. 9. Luo, Y.; Yao, J. P.; Yang, L.; Feng, C. L.; Tang, W.; Wang, G. F.; Zuo, J. P.; Lu, W., Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus. Bioorgan Med Chem 2010, 18 (14), 5048-5055. 10. Singla, P.; Luxami, V.; Paul, K., Benzimidazole-biologically attractive scaffold for protein kinase inhibitors. Rsc Adv 2014, 4 (24), 12422-12440. 11. Achar, K. C. S.; Hosamani, K. M.; Seetharamareddy, H. R., In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives. Eur J Med Chem 2010, 45 (5), 2048-2054. 12. Refaat, H. M., Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives. Eur J Med Chem 2010, 45 (7), 2949-2956. 13. Azam, M.; Khan, A. A.; Al-Resayes, S. I.; Islam, M. S.; Saxena, A. K.; Dwivedi, S.; Musarrat, J.; Trzesowska-Kruszynska, A.; Kruszynski, R., Synthesis and characterization of 2-substituted benzimidazoles and their evaluation as anticancer agent. Spectrochim Acta A 2015, 142, 286-291. 14. Di Carlo, G.; Mascolo, N.; Izzo, A. A.; Capasso, F., Flavonoids: Old and new aspects of a class of natural therapeutic drugs. Life Sci 1999, 65 (4), 337-353. 15. Nowakowska, Z., A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem 2007, 42 (2), 125-137. 16. Pettit, G. R.; Rhodes, M. R.; Herald, D. L.; Hamel, E.; Schmidt, J. M.; Pettitt, R. K., Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-4. J Med Chem 2005, 48 (12), 4087-4099. 17. Sivakumar, P. M.; Ganesan, S.; Veluchamy, P.; Doble, M., Novel chalcones and 1,3,5-triphenyl-2-pyrazoline derivatives as antibacterial agents. Chem Biol Drug Des 2010, 76 (5), 407-411. 18. Agarwal, A.; Srivastava, K.; Puri, S. K.; Chauhan, P. M. S., Synthesis of substituted indole derivatives as a new class of antimalarial agents. Bioorg Med Chem Lett 2005, 15 (12), 3133-3136. 19. Suwito, H.; Jumina; Mustofa; Pudjiastuti, P.; Fanani, M. Z.; Kimata-Ariga, Y.; Katahira, R.; Kawakami, T.; Fujiwara, T.; Hase, T.; Sirat, H. M.; Puspaningsih, N. N. T., Design and Synthesis of Chalcone Derivatives as Inhibitors of the Ferredoxin - Ferredoxin-NADP(+) Reductase Interaction of Plasmodium falciparum: Pursuing New Antimalarial Agents. Molecules 2014, 19 (12), 21473-21488. 20. Boeck, P.; Leal, P. C.; Yunes, R. A.; Cechinel, V.; Lopez, S.; Sortino, M.; Escalante, A.; Furlan, R. L. E.; Zacchino, S., Antifungal activity and studies on mode of action of novel xanthoxyline-derived chalcones. Arch Pharm 2005, 338 (2-3), 87-95. 21. Cheenpracha, S.; Karalai, C.; Ponglimanont, C.; Subhadhirasakul, S.; Tewtrakul, S., Anti-HIV-1 protease activity of compounds from Boesenbergia pandurata. Bioorgan Med Chem 2006, 14 (6), 1710-1714. 22. Mateeva, N.; Gangapuram, M.; Mazzio, E.; Eyunni, S.; Soliman, K. F. A.; Redda, K. K., Biological evaluation of synthetic chalcone and flavone derivatives as anti-inflammatory agents. Med Chem Res 2015, 24 (4), 1672-1680. 23. Kim, T. H.; Seo, W. D.; Ryu, H. W.; Seo, H. R.; Jin, Y. B.; Lee, M.; Ji, Y. H.; Park, K. H.; Lee, Y. S., Anti-tumor effects by a synthetic chalcone compound is mediated by c-Myc-mediated reactive oxygen species production. Chem-Biol Interact 2010, 188 (1), 111-118. 24. Quintin, J.; Desrivot, J.; Thoret, S.; Le Menez, P.; Cresteil, T.; Lewin, G., Synthesis and biological evaluation of a series of tangeretin-derived chalcones. Bioorg Med Chem Lett 2009, 19 (1), 167-169. 25. Kamal, A.; Prabhakar, S.; Ramaiah, M. J.; Reddy, P. V.; Reddy, C. R.; Mallareddy, A.; Shankaraiah, N.; Reddy, T. L. N.; Pushpavalli, S. N. C. V. L.; Pal-Bhadra, M., Synthesis and anticancer activity of chalcone-pyrrolobenzodiazepine conjugates linked via 1,2,3-triazole ring side-armed with alkane spacers. Eur J Med Chem 2011, 46 (9), 3820-3831. 26. Modzelewska, A.; Pettit, C.; Achanta, G.; Davidson, N. E.; Huang, P.; Khan, S. R., Anticancer activities of novel chalcone and bis-chalcone derivatives. Bioorgan Med Chem 2006, 14 (10), 3491-3495. 27. Wan, M. S.; Xu, L. Y.; Hua, L.; Li, A. L.; Li, S. Q.; Lu, W. J.; Pang, Y.; Cao, C. B.; Liu, X. G.; Jiao, P., Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents. Bioorg Chem 2014, 54, 38-43. 28. Solomon, V. R.; Hu, C. K.; Lee, H., Hybrid pharmacophore design and synthesis of isatin-benzothiazole analogs for their anti-breast cancer activity. Bioorgan Med Chem 2009, 17 (21), 7585-7592. 29. He, S. W.; Hong, Q. M.; Lai, Z.; Yang, D. X.; Ting, P. C.; Kuethe, J. T.; Cernak, T. A.; Dykstra, K. D.; Sperbeck, D. M.; Wu, Z. C.; Yu, Y.; Yang, G. X.; Jian, T. Y.; Liu, J.; Guiadeen, D.; Krikorian, A. D.; Sonatore, L. M.; Wiltsie, J.; Liu, J. Q.; Gorski, J. N.; Chung, C. C.; Gibson, J. T.; Lisnock, J.; Xiao, J. Y.; Wolff, M.; Tong, S. X.; Madeira, M.; Karanam, B. V.; Shen, D. M.; Balkovec, J. M.; Pinto, S.; Nargund, R. P.; DeVita, R. J., Discovery of a Potent and Selective DGAT1 Inhibitor with a Piperidinyl-oxy-cyclohexanecarboxylic Acid Moiety. Acs Med Chem Lett 2014, 5 (10), 1082-1087. 30. Shaharyar, M.; Abdullah, M. M.; Bakht, M. A.; Majeed, J., Pyrazoline bearing benzimidazoles: Search for anticancer agent. Eur J Med Chem 2010, 45 (1), 114-119. 31. Ouattara, M.; Sissouma, D.; Kone, M. W.; Menan, H. E.; Toure, S. A.; Ouattara, L., Synthesis and anthelmintic activity of some hybrid Benzimidazolyl-chalcone derivatives. Trop J Pharm Res 2011, 10 (6), 767-775. 32. Reddy, V. M.; Reddy, K. R., Synthesis and biological evaluation of some novel-3-(5-substituted benzimidazol-2-yl)-5-arylisoxazolines. Chinese Chem Lett 2010, 21 (10), 1145-1148. 33. Mathew, B.; Suresh, J.; Vinod, D., Antitumour activity of 5-[(2E)-1-(1H-benzimidazol-2-yl)-3-substituted phenylprop-2-en-1-ylidene] pyrimidine-2,4,6(1H,3H,5H)-triones against Dalton's ascitic lymphoma in mice. Med Chem Res 2013, 22 (8), 3911-3917. 34. Woo, H. B.; Eom, Y. W.; Park, K. S.; Ham, J.; Ahn, C. M.; Lee, S., Synthesis of substituted benzimidazolyl curcumin mimics and their anticancer activity. Bioorg Med Chem Lett 2012, 22 (2), 933-936. 35. Hayes, M. E.; Wallace, G. A.; Grongsaard, P.; Bischoff, A.; George, D. M.; Miao, W. Y.; McPherson, M. J.; Stoffel, R. H.; Green, D. W.; Roth, G. P., Discovery of small molecule benzimidazole antagonists of the chemokine receptor CXCR3. Bioorg Med Chem Lett 2008, 18 (5), 1573-1576. 36. Mehboob, S.; Song, J. H.; Hevener, K. E.; Su, P. C.; Boci, T.; Brubaker, L.; Truong, L.; Mistry, T.; Deng, J. P.; Cook, J. L.; Santarsiero, B. D.; Ghosh, A. K.; Johnson, M. E., Structural and biological evaluation of a novel series of benzimidazole inhibitors of Francisella tularensis enoyl-ACP reductase (FabI). Bioorg Med Chem Lett 2015, 25 (6), 1292-1296. 37. Sharma, A.; Luxami, V.; Paul, K., Synthesis, single crystal and antitumor activities of benzimidazole-quinazoline hybrids. Bioorg Med Chem Lett 2013, 23 (11), 3288-3294. 38. Hwu, J. R.; Hsu, M. H.; Huang, R. C. C., New nordihydroguaiaretic acid derivatives as anti-HIV agents. Bioorg Med Chem Lett 2008, 18 (6), 1884-1888. 39. Orjales, A.; Alonso-Cires, L.; Lopez-Tudanca, P.; Tapia, I.; Mosquera, R.; Labeaga, L., Benzimidazole-2-carboxylic acid amides and esters: a new structural class of 5-HT(3) ligands. Eur J Med Chem 1999, 34 (5), 415-422. 40. Saleshier, F. M.; Suresh.S; .N, A.; JubinaKarim; Madhu.C.Divakar, Design, docking and synthesis of some 6-benzimidazoyl pyrans and screening of their anti tubercular activity. European Journal of Experimental Biology 2011, 1 (2), 150-159. 41. V., D. J.; Chavan Rashmi S.; Chaudhari Nileshwari S; Patil, D. S. T., A short review on chemistry and potential activities of benzimidazole molecule. IJPT 2013, 5 (1), 2477-2494. 42. Noolvi, M. N.; Patel, H. M.; Bhardwaj, V.; Chauhan, A., Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: Search for anticancer agent. Eur J Med Chem 2011, 46 (6), 2327-2346. 43. Carpino, L. A., A Simple Preparation of Active Manganese Dioxide from Activated Carbon. J Org Chem 1970, 35 (11), 3971-1372.
|